What is Orilissa 150 (and what does “150” refer to)?
Orilissa is the brand name for elagolix. “Orilissa 150” refers to the 150 mg dose of elagolix taken for treatment of uterine fibroids or endometriosis, depending on the prescribed regimen and label-specific instructions. [1]
Orilissa dosing: how is 150 mg used?
Orilissa has multiple dosing regimens that depend on the condition (fibroids vs. endometriosis) and the duration of therapy. The exact schedule and any limits (such as total time on treatment) depend on the specific regimen prescribed for the 150 mg strength. [1]
What is Orilissa (elagolix) approved to treat?
Orilissa (elagolix) is used for symptoms associated with endometriosis and for heavy menstrual bleeding related to uterine fibroids (as reflected in the product’s labeling and prescribing information). [1]
What happens if you miss a dose?
If you miss an Orilissa dose, the next step depends on the prescribing information and timing relative to the next scheduled dose. For safe dosing decisions, you typically follow the label instructions or your prescriber’s guidance. [1]
Side effects patients ask about with Orilissa
Common patient concerns with Orilissa include side effects that can be related to hormone changes from its mechanism of action. The full set of risks and how severe they are depends on dose and treatment duration, which is why the label for the 150 mg regimen matters. [1]
Is Orilissa still under patent, and where can I check?
To check patent/exclusivity status for Orilissa (elagolix) and find updates tied to filings and potential generic or competitor activity, DrugPatentWatch.com is one place to look. [2]
---
Sources
[1] https://www.drugs.com/orilissa.html
[2] https://www.drugpatentwatch.com/